| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.31B | 14.26B | 14.21B | 13.69B | 14.30B | 12.76B |
| Gross Profit | 4.35B | 4.26B | 4.23B | 3.94B | 4.21B | 3.80B |
| EBITDA | 2.25B | 2.23B | 2.37B | 2.22B | 2.30B | 1.82B |
| Net Income | 1.35B | 1.65B | 1.41B | 1.25B | 1.25B | 906.00M |
Balance Sheet | ||||||
| Total Assets | 10.77B | 11.32B | 10.12B | 9.82B | 12.28B | 10.71B |
| Cash, Cash Equivalents and Short-Term Investments | 840.00M | 2.30B | 1.27B | 1.19B | 1.56B | 1.78B |
| Total Debt | 8.49B | 8.74B | 7.31B | 7.21B | 7.79B | 6.50B |
| Total Liabilities | 16.06B | 16.04B | 14.84B | 14.48B | 15.26B | 13.91B |
| Stockholders Equity | -5.42B | -4.85B | -4.92B | -4.87B | -3.63B | -3.86B |
Cash Flow | ||||||
| Free Cash Flow | 1.32B | 1.44B | 1.49B | 1.45B | 1.59B | 1.30B |
| Operating Cash Flow | 1.47B | 1.56B | 1.63B | 1.56B | 1.75B | 1.48B |
| Investing Cash Flow | -330.00M | -239.00M | -183.00M | -33.00M | -89.00M | -353.00M |
| Financing Cash Flow | -1.10B | -234.00M | -1.35B | -3.65B | 58.00M | -844.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $117.22B | 33.42 | 27.30% | 0.79% | 0.22% | 26.66% | |
76 Outperform | $81.66B | 36.17 | 10.91% | 1.58% | 2.97% | 18.14% | |
71 Outperform | $73.84B | 24.92 | 91.71% | 2.43% | -0.41% | -10.88% | |
71 Outperform | $46.56B | 54.38 | 24.24% | 1.33% | 0.98% | -7.51% | |
69 Neutral | $34.00B | 63.67 | 5.35% | 0.10% | 4.20% | -34.47% | |
67 Neutral | $34.88B | 26.45 | ― | 1.88% | 0.73% | -15.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |